News
TipRanks on MSN13h
Hims & Hers down 2% as GoodRx expands Ozempic, Wegovy access
Shares of Hims & Hers (HIMS) are down 92c, or 2%, to $45.09 in pre-market trading after GoodRx (GDRX) announced that all strengths of Ozempic and ...
TipRanks on MSN15h
Hims & Hers price target lowered to $37 from $48 at Truist
Truist lowered the firm’s price target on Hims & Hers to $37 from $48 and keeps a Hold rating on the shares. The firm’s intra-quarter Truist Card ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback